TaiGen Biopharmaceuticals Holdings Ltd

NEW
ROCO:4157 (Taiwan)  
NT$ 9.85 +0.25 (+2.6%) Apr 29
At Loss
P/B:
6.53
Market Cap:
NT$ 7.07B ($ 220.50M)
Enterprise V:
NT$ 6.11B ($ 190.53M)
Volume:
413.16K
Avg Vol (2M):
739.92K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
413.16K
At Loss
Avg Vol (2M):
739.92K

TaiGen Biopharmaceuticals Holdings Ltd’s share price is NT$9.85. Its GF Value is NT$17.18. Based on the relationship between the current stock price and the GF Value, GuruFocus believes TaiGen Biopharmaceuticals Holdings Ltd stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: NT$9.85 GF Value Price/GF Value
Current NT$17.18 0.57
Next FY1 End NT$15.02 0.66
Next 12 Month NT$14.15 0.70
Next FY2 End NT$12.38 0.80
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing TaiGen Biopharmaceuticals Holdings Ltd's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The findings reveal that TaiGen Biopharmaceuticals Holdings Ltd's stock price shows no significant correlation with any of these four metrics.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies